Morningstar Rating

Stock Research and Analysis

by Neal Dihora, CFA

Bulls Say

We estimate that around 16% of Moog's sales have a somewhat recurring nature, including aftermarket sales for aircraft, industrial machinery markets, and medical pump administration sets.
Many aircraft platforms, including the Boeing 787 and Airbus A350, are moving from development to production, which should drive strong top- and bottom-line results.
Moog has decided to begin a 4-million-share repurchase program, and we think this is a good capital allocation decision as acquisition prices have increased. Read more 

Bears Say

Moog has decided to sell its medical division, but if a buyer does not come forth, the firm may need to fix operations.
Moog has expended significant R&D resources as a supplier on the Boeing 787 Dreamliner. The company could experience a similar issue with the Airbus A350 platform.
Class A shares have one tenth the voting rights of Class B shares. There are 41 million Class A shares and 4.5 million Class B shares outstanding. Read more 


The firm is led by John Scannell, who took over from longtime CEO Robert Brady in December 2011. He has been with Moog for 22 years, but his ability to maneuver the firm through economic cycles is untested. To date, he's been active in restructuring   Read more 


Moog is a worldwide designer, manufacturer, and integrator of precision control components and systems used in military and commercial aircraft (39% of fiscal 2012 revenue),  Read more 

First Name
Last Name
Email Address
Zip Code
Create Password
Verify Password
(6-15 characters; case sensitive)

Slimmed-Down P&G Worth a Closer Look 
Watch more 

Premium Membership

View all of our analyst reports with a free trial to Premium.